19 May 2013
Keywords: avigen, resumes, ph, trial, coagulin-b, shares, usa-based
Article | 15 September 2003
Shares of USA-based Avigen rose 10% to $4.93 on the afternoon of September 9, the day the company announced that it had received
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com